NovoCure (NVCR) Raw Materials (2014 - 2019)

NovoCure has disclosed Raw Materials across 6 years of filings, most recently posting $3.4 million for Q2 2019.

• Raw Materials for Q2 2019 came in at $3.4 million, up 36.2% year-over-year; the trailing twelve-month figure through Jun 2019 was $3.4 million (up 36.2% YoY), and the FY2018 annual result was $870000.0, down 79.65% from the prior year.
• Raw Materials came in at $3.4 million for Q2 2019 at NovoCure, up from $1.5 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $5.9 million in Q3 2017 to a low of $870000.0 in Q4 2018.
• The 5-year median for Raw Materials is $3.6 million (2015), against an average of $3.6 million.
• Across the five-year window, Raw Materials soared 568.82% in 2015 and slumped 79.65% in 2018, its largest moves.
• NovoCure's Raw Materials stood at $3.5 million in 2015, then jumped by 49.03% to $5.2 million in 2016, then decreased by 18.44% to $4.3 million in 2017, then plunged by 79.65% to $870000.0 in 2018, then jumped by 294.37% to $3.4 million in 2019.
• The last three Raw Materials figures came in at $3.4 million (Q2 2019), $1.5 million (Q1 2019), and $870000.0 (Q4 2018), per Business Quant data.